Evidence map›Paper›PMID 33428470›Full record

ArticleJCO oncology practice2021

Disparities in Characteristics, Access to Care, and Oncologic Outcomes in Young-Onset Colorectal Cancer at a Safety-Net Hospital.

Benjamin D Fangman, Suleyman Y Goksu, Nivan Chowattukunnel, Muhammad S Beg, Nina N Sanford, Aravind Sanjeevaiah, John Cox, Michael R Folkert, Todd A Aguilera, Joselin Mathews and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in JCO oncology practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 1 institution in 1 country.

Benjamin D FangmanDepartment of Internal Medicine, UT Southwestern Medical Center, Dallas, TX.ORCID 0000-0003-2437-0738
Suleyman Y GoksuDepartment of Internal Medicine, UT Southwestern Medical Center, Dallas, TX.ORCID 0000-0001-9453-342X
Nivan ChowattukunnelDepartment of Internal Medicine, UT Southwestern Medical Center, Dallas, TX.
Muhammad S BegDivision of Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX.ORCID 0000-0002-3754-6627
Nina N SanfordDepartment of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX.ORCID 0000-0001-7840-5700
Aravind SanjeevaiahDivision of Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX.ORCID 0000-0001-7742-1442
John CoxDivision of Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX.ORCID 0000-0002-4503-2415
Michael R FolkertDepartment of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX.ORCID 0000-0002-2886-0956
Todd A AguileraDepartment of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX.ORCID 0000-0002-3734-3758
Joselin MathewsDepartment of Surgery, UT Southwestern Medical Center, Dallas, TX.
Javier Salgado PogacnikDepartment of Surgery, UT Southwestern Medical Center, Dallas, TX.
Gaurav KhatriDepartment of Radiology, UT Southwestern Medical Center, Dallas, TX.
Craig OlsonDepartment of Surgery, UT Southwestern Medical Center, Dallas, TX.
Patricio M PolancoDepartment of Surgery, UT Southwestern Medical Center, Dallas, TX.
Udit VermaDivision of Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX.
David HsiehchenDivision of Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX.
Amy JonesDivision of Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX.
Radhika KainthlaDivision of Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX.
Syed M KazmiDivision of Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX.ORCID 0000-0002-3367-367X
Southwestern Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeYoung-onset colorectal cancer is an emerging cause of significant morbidity and mortality globally. Despite this, limited data exist regarding clinical characteristics and outcomes, particularly in safety-net populations where access to care is limited. We aimed to study disparities in clinical characteristics and outcomes in patients with young-onset colorectal cancer in the safety-net setting.

methodsWe performed a retrospective review of patients < 50 years old diagnosed and/or treated for colorectal cancer between 2001 and 2017 at a safety-net hospital. Kaplan-Meier and Cox regression models were constructed to compare overall survival (OS), progression-free survival (PFS), and relapse-free survival (RFS) by race and ethnicity, stratifying for relevant clinical and pathologic factors.

resultsA total of 395 young-onset patients diagnosed at a safety-net hospital were identified and 270 were included in the analysis (49.6% Hispanic, 25.9% non-Hispanic Black, 20.0% non-Hispanic White, and 4.4% other). Non-Hispanic White race was independently associated with worse OS (hazzard ratio [HR], 0.53; 95% CI, 0.29 to 0.97), as were lack of insurance, higher clinical stage, and mismatch repair proficiency. There was no significant difference seen in PFS or RFS between racial and ethnic groups.

conclusionNon-Hispanic White race or ethnicity was found to be independently associated with worse OS in a safety-net population of patients with young-onset colorectal cancer. Other independent predictors of worse OS include higher stage, lack of insurance, and mismatch repair proficiency.

Indexed as

Colorectal NeoplasmsSafety-net ProvidersHealth Services AccessibilityHumansMiddle AgedRetrospective StudiesWhite People

Identifiers

PMID33428470
PMCPMC8120665
OpenAlexW3121053414

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.